Invention Grant
- Patent Title: Inhibition and treatment of bacterial infections by sex-specific GPER targeting
-
Application No.: US16067721Application Date: 2017-01-09
-
Publication No.: US10561648B2Publication Date: 2020-02-18
- Inventor: Pamela Hall , Eric R. Prossnitz , Helen J. Hathaway
- Applicant: STC.UNM
- Applicant Address: US NM Albuquerque
- Assignee: STC.UNM
- Current Assignee: STC.UNM
- Current Assignee Address: US NM Albuquerque
- Agent Henry D. Colemam; R. Neil Sudol
- International Application: PCT/US2017/012687 WO 20170109
- International Announcement: WO2017/123492 WO 20170720
- Main IPC: A61K31/473
- IPC: A61K31/473 ; A61K45/06 ; A61K35/644 ; A61K38/14 ; C07K14/705 ; A61K31/4741 ; A61P31/04
Abstract:
The present invention is directed to the use of compounds which are modulators of the G protein-Coupled Estrogen Receptor (GPER) for the inhibition —and/or treatment of Bacterial infections, especially including metMctHin-resistant Staphylococcus aureus (MRSA) infections. Pharmaceutical compositions and methods of treatment of bacterial pathogens, including MRSA are also described.
Public/Granted literature
- US20190000830A1 INHIBITION AND TREATMENT OF BACTERIAL INFECTIONS BY SEX-SPECIFIC GPER TARGETING Public/Granted day:2019-01-03
Information query
IPC分类:
